Oncology PracticeNivolumab falls short in ccRCC patients with brain metastasesAugust 28, 2019Renal Cell CarcinomaImmunotherapyImmuno-oncology
Oncology PracticeStudy outlines survival factors with nivolumabJuly 25, 2019Lung CancerRenal Cell CarcinomaMelanomaImmuno-oncology
Oncology PracticeFDA approves bevacizumab-bvzr for several cancersJune 28, 2019Gynecologic CancerRenal Cell CarcinomaLung CancerGastroenterologyGenitourinary CancerCNS/Brain CancerNeuro-oncology
Oncology PracticeNephrectomy may benefit select renal cancer patients based on risk factorsJune 5, 2019Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeTrial matches pediatric cancer patients to targeted therapiesMay 31, 2019Sarcoma & GISTPediatricsRenal Cell CarcinomaCNS/Brain CancerGenitourinary CancerPediatric Neuroblastoma
Oncology PracticeModel shows nivolumab plus ipilimumab cost effective in mRCCFebruary 25, 2019Practice ManagementGenitourinary CancerRenal Cell CarcinomaImmuno-oncologyBusiness of Medicine
Oncology PracticeTivozanib has PFS benefit over sorafenib in hard-to-treat RCCFebruary 24, 2019Renal Cell Carcinoma
Oncology PracticeFirst-line avelumab/axitinib for RCC benefits wide range of patientsFebruary 21, 2019Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Oncology PracticePembrolizumab-axitinib nearly halves risk of death in RCCFebruary 12, 2019Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Oncology PracticeSevere adverse events seen in placebo arm of cancer clinical trialsDecember 13, 2018Immuno-oncologyRenal Cell Carcinoma
Oncology Practice‘Optimal’ pazopanib levels linked to lower toxicity in RCC patientsDecember 13, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeCytoreductive nephrectomy may benefit RCC patients with brain metsDecember 12, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeLipoprotein ratio linked to poor survival in metastatic RCCDecember 11, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeRCC strongly linked to melanoma, and vice versaDecember 10, 2018Renal Cell CarcinomaGenitourinary CancerMelanoma
Oncology PracticeRCC research has opened door to the future, but “much work remains to be done”December 5, 2018Renal Cell Carcinoma
